These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 35790291)
1. SOCS1 Gene Therapy for Head and Neck Cancers: An Experimental Study. Kajiyama T; Serada S; Fujimoto M; Ohkawara T; Komori M; Hyodo M; Naka T Anticancer Res; 2022 Jul; 42(7):3361-3372. PubMed ID: 35790291 [TBL] [Abstract][Full Text] [Related]
3. Suppressor of cytokine signaling-1 gene therapy induces potent antitumor effect in patient-derived esophageal squamous cell carcinoma xenograft mice. Sugase T; Takahashi T; Serada S; Nakatsuka R; Fujimoto M; Ohkawara T; Hara H; Nishigaki T; Tanaka K; Miyazaki Y; Makino T; Kurokawa Y; Yamasaki M; Nakajima K; Takiguchi S; Kishimoto T; Mori M; Doki Y; Naka T Int J Cancer; 2017 Jun; 140(11):2608-2621. PubMed ID: 28233302 [TBL] [Abstract][Full Text] [Related]
4. Epigenetic modification of SOCS-1 differentially regulates STAT3 activation in response to interleukin-6 receptor and epidermal growth factor receptor signaling through JAK and/or MEK in head and neck squamous cell carcinomas. Lee TL; Yeh J; Van Waes C; Chen Z Mol Cancer Ther; 2006 Jan; 5(1):8-19. PubMed ID: 16432158 [TBL] [Abstract][Full Text] [Related]
5. SOCS1 gene therapy has antitumor effects in imatinib-resistant gastrointestinal stromal tumor cells through FAK/PI3 K signaling. Sugase T; Takahashi T; Serada S; Fujimoto M; Ohkawara T; Hiramatsu K; Nishida T; Hirota S; Saito Y; Tanaka K; Miyazaki Y; Makino T; Kurokawa Y; Yamasaki M; Nakajima K; Hanasaki K; Kishimoto T; Mori M; Doki Y; Naka T Gastric Cancer; 2018 Nov; 21(6):968-976. PubMed ID: 29623544 [TBL] [Abstract][Full Text] [Related]
6. Resveratrol inhibits STAT3 signaling pathway through the induction of SOCS-1: Role in apoptosis induction and radiosensitization in head and neck tumor cells. Baek SH; Ko JH; Lee H; Jung J; Kong M; Lee JW; Lee J; Chinnathambi A; Zayed ME; Alharbi SA; Lee SG; Shim BS; Sethi G; Kim SH; Yang WM; Um JY; Ahn KS Phytomedicine; 2016 May; 23(5):566-77. PubMed ID: 27064016 [TBL] [Abstract][Full Text] [Related]
7. Potent antitumor activity of oncolytic adenovirus-mediated SOCS1 for hepatocellular carcinoma. Liu L; Li W; Wei X; Cui Q; Lou W; Wang G; Hu X; Qian C Gene Ther; 2013 Jan; 20(1):84-92. PubMed ID: 22318090 [TBL] [Abstract][Full Text] [Related]
8. JAK kinase inhibition abrogates STAT3 activation and head and neck squamous cell carcinoma tumor growth. Sen M; Pollock NI; Black J; DeGrave KA; Wheeler S; Freilino ML; Joyce S; Lui VW; Zeng Y; Chiosea SI; Grandis JR Neoplasia; 2015 Mar; 17(3):256-64. PubMed ID: 25810010 [TBL] [Abstract][Full Text] [Related]
9. Specific function of STAT3, SOCS1, and SOCS3 in the regulation of proliferation and survival of classical Hodgkin lymphoma cells. Baus D; Pfitzner E Int J Cancer; 2006 Mar; 118(6):1404-13. PubMed ID: 16206268 [TBL] [Abstract][Full Text] [Related]
10. SOCS1 gene transfer accelerates the transition to heart failure through the inhibition of the gp130/JAK/STAT pathway. Cittadini A; Monti MG; Iaccarino G; Castiello MC; Baldi A; Bossone E; Longobardi S; Marra AM; Petrillo V; Saldamarco L; During MJ; Saccà L; Condorelli G Cardiovasc Res; 2012 Dec; 96(3):381-90. PubMed ID: 22875468 [TBL] [Abstract][Full Text] [Related]
11. SOCS1 counteracts ROS-mediated survival signals and promotes apoptosis by modulating cell cycle to increase radiosensitivity of colorectal cancer cells. Ryu JY; Oh J; Kim SM; Kim WG; Jeong H; Ahn SA; Kim SH; Jang JY; Yoo BC; Kim CW; Lee CE BMB Rep; 2022 Apr; 55(4):198-203. PubMed ID: 35321782 [TBL] [Abstract][Full Text] [Related]
12. SOCS-3 is frequently methylated in head and neck squamous cell carcinoma and its precursor lesions and causes growth inhibition. Weber A; Hengge UR; Bardenheuer W; Tischoff I; Sommerer F; Markwarth A; Dietz A; Wittekind C; Tannapfel A Oncogene; 2005 Oct; 24(44):6699-708. PubMed ID: 16007169 [TBL] [Abstract][Full Text] [Related]
13. MEK Inhibitor PD-0325901 Overcomes Resistance to PI3K/mTOR Inhibitor PF-5212384 and Potentiates Antitumor Effects in Human Head and Neck Squamous Cell Carcinoma. Mohan S; Vander Broek R; Shah S; Eytan DF; Pierce ML; Carlson SG; Coupar JF; Zhang J; Cheng H; Chen Z; Van Waes C Clin Cancer Res; 2015 Sep; 21(17):3946-56. PubMed ID: 25977343 [TBL] [Abstract][Full Text] [Related]
15. Suppressor of cytokine signaling (SOCS) genes are downregulated in breast cancer. Ghafouri-Fard S; Oskooei VK; Azari I; Taheri M World J Surg Oncol; 2018 Nov; 16(1):226. PubMed ID: 30453988 [TBL] [Abstract][Full Text] [Related]
16. Suppressor of cytokine signaling 1 protects rat pancreatic islets from cytokine-induced apoptosis through Janus kinase/signal transducers and activators of transcription pathway. Sun Q; Xiang RL; Yang YL; Feng K; Zhang K; Ding WY Chin Med J (Engl); 2013 Nov; 126(21):4048-53. PubMed ID: 24229672 [TBL] [Abstract][Full Text] [Related]
17. Molecular mechanism underlying the antiproliferative effect of suppressor of cytokine signaling-1 in non-small-cell lung cancer cells. Shimada K; Serada S; Fujimoto M; Nomura S; Nakatsuka R; Harada E; Iwahori K; Tachibana I; Takahashi T; Kumanogoh A; Kishimoto T; Naka T Cancer Sci; 2013 Nov; 104(11):1483-91. PubMed ID: 23962256 [TBL] [Abstract][Full Text] [Related]
18. RNF7 inhibits apoptosis and sunitinib sensitivity and promotes glycolysis in renal cell carcinoma via the SOCS1/JAK/STAT3 feedback loop. Xiao C; Zhang W; Hua M; Chen H; Yang B; Wang Y; Yang Q Cell Mol Biol Lett; 2022 May; 27(1):36. PubMed ID: 35562668 [TBL] [Abstract][Full Text] [Related]
19. Acute alcohol intake induces SOCS1 and SOCS3 and inhibits cytokine-induced STAT1 and STAT3 signaling in human monocytes. Norkina O; Dolganiuc A; Catalano D; Kodys K; Mandrekar P; Syed A; Efros M; Szabo G Alcohol Clin Exp Res; 2008 Sep; 32(9):1565-73. PubMed ID: 18616672 [TBL] [Abstract][Full Text] [Related]
20. Type III Interferon Induces Distinct SOCS1 Expression Pattern that Contributes to Delayed but Prolonged Activation of Jak/STAT Signaling Pathway: Implications for Treatment Non-Response in HCV Patients. Liu B; Chen S; Guan Y; Chen L PLoS One; 2015; 10(7):e0133800. PubMed ID: 26193702 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]